ESSENTIALS OF DIAGNOSIS
Hypertension may be severe or drug-resistant.
Hypokalemia (in minority of patients) may cause polyuria, polydipsia, muscle weakness.
Low plasma renin; elevated plasma and urine aldosterone levels.
Primary aldosteronism (hyperaldosteronism) refers to an inappropriately high aldosterone secretion that does not suppress adequately with sodium loading. Most affected patients have hypertension, although some may be normotensive. Primary aldosteronism is common and is believed to account about 8% of cases of stage 2 (mild) hypertension and about 13% of cases of stage 3 (moderate) hypertension. It should be suspected with early-onset hypertension or stroke before age 50 years (or both). It may be difficult to distinguish primary aldosteronism from cases of low renin essential hypertension, with which it may overlap. Patients of all ages may be affected, but the peak incidence is between 30 years and 60 years. Excessive aldosterone production increases sodium retention and suppresses plasma renin. It increases renal potassium excretion, which can lead to hypokalemia. Cardiovascular events are more prevalent in patients with aldosteronism (35%) than in those with essential hypertension (11%).
Primary aldosteronism may be caused by a unilateral aldosterone-producing adrenal cortical adenoma (Conn syndrome, 25%) that is more common in women with a 2:1 ratio, peaking between ages 30 and 50. However, primary aldosteronism is more commonly caused by adrenal cortical hyperplasia (75%) that is more common in men with a 4:1 ratio, peaking between ages 50 and 60. It is important to distinguish the two, since a unilateral aldosteronoma (Conn syndrome) may be cured by surgical resection, whereas patients with bilateral adrenal hyperplasia are treated medically.
Unilateral aldosterone-producing adrenal adenoma (Conn syndrome) have been found to have somatic mutations in a gene involved with potassium channels (40%). Primary aldosterone has been caused rarely by malignant ovarian tumors. Bilateral aldosteronism may be corticosteroid-suppressible, due to an autosomal-dominant genetic defect allowing ACTH stimulation of aldosterone production.
Primary aldosteronism is the most common cause of refractory hypertension in youths and middle-aged adults. Patients have hypertension that is typically moderate but may be severe. Some patients have only diastolic hypertension, without other symptoms and signs. Edema is rarely seen in primary aldosteronism. Hypokalemia can produce muscle weakness (at times with paralysis simulating periodic paralysis), paresthesias with frank tetany, headache, polyuria, and polydipsia.
Plasma potassium should be determined in hypertensive individuals. However, hypokalemia, once thought to be the hallmark of hyperaldosteronism, is present in only 37% of affected patients: 50% of those with an aldosterone-producing adenoma and 17% of those with adrenal hyperplasia. An elevated serum bicarbonate (HCO3) concentration indicates metabolic alkalosis and is commonly present.
Testing for primary aldosteronism should be done for all hypertensive patients with any of the following: (1) sustained hypertension above 150/100 mm Hg ...